Table 1.

Baseline data.

	Minor SAH (n; %)	Moderate SAH (n; %)	Severe SAH (n; %)	p-value minor/moderate	p-value minor/severe	p-value moderate/severe
Treatment regime
ICU	41 (51.3%)	38 (47.5%)	56 (70%)	0.75	0.02*	0.006*
IMCU	29 (36.3%)	30 (37.5%)	17 (21.3%)	1.0	0.003*	0.04*
Regular ward	4 (5.0%)	6 (7.5%)	1 (1.3%)	0.75	0.37	0.12
BP monitoring
Invasive BP monitoring	42 (52.5%)	44 (55.0%)	57 (71.3%)	0.87	0.02*	0.048*
Non-invasive BP monitoring	33 (41.3%)	30 (37.5%)	20 (25.0%)	0.75	0.04*	0.12
No BP monitoring	4 (5.0%)	4 (5.0%)	2 (2.5%)	1.0	0.68	0.68
CV prophylaxis
CV prophylaxis + TCD	33 (41.3%)	36 (45.0%)	51 (63.8%)	0.75	0.007*	0.03*
CV prophylaxis without TCD	5 (6.3%)	5 (6.3%)	7 (8.8%)	1.0	0.77	0.77
No CV prophylaxis but TCD	24 (30.0%)	26 (32.5%)	18 (21.3%)	0.86	0.37	0.22
Neither CV prophylaxis nor TCD	18 (22.5%)	13 (16.3%)	4 (5.0%)	0.42	0.002*	0.04*
Second DSA
Within 3 weeks	34 (42.5%)	35 (43.8%)	47 (58.8%)	1.0	0.06	0.08
6–12 weeks	17 (21.3%)	19 (23.8%)	18 (22.5%)	0.85	1.0	1.0
6–12 months	2 (2.5%)	3 (3.8%)	4 (5.0%)	1.0	0.07	1.0
No second DSA	27 (33.8%)	22 (27.5%)	11 (13.8%)	0.49	0.005*	0.049*
Third DSA
Third DSA	3 (3.8%)	3 (3.8%)	11 (13.8%)	1.0	0.05	0.05
No third DSA	53 (66.3%)	55 (68.8%)	55 (68.8)	0.86	0.86	1.0

*Denotes statistical significance.